Roche, Sanofi Double Down On Post-Coronavirus China With Oncology Alliances
Attractions As A Rising Innovator
In a bid widely seen as a move to double down on their “in China for China” strategy, Sanofi and Roche have formed new drug development alliances with local innovative players potentially worth billions.
